Updated:
Xponentia Capital Partners
P.R. Srinivasan leads Xponentia Capital Partners, an India mid-market PE firm writing $15–25M equity checks in enterprise tech and financial services.
Xponentia Capital Partners
Srinivasan founded Xponentia in Mumbai in 2014 after leading India investments for Citi's proprietary private equity arm, a platform that deployed over $1 billion in the region during his tenure. The firm sealed its first close on Fund I in 2016 and reached a final close the following year, raising capital from domestic institutions and family offices to target India's underserved mid-market. Unlike the mega-funds crowding India's late-stage and infrastructure spaces, Xponentia focuses on companies with $10–50 million in revenue that need operational capital rather than pure growth equity. Xponentia deploys across enterprise technology, financial services, healthcare, consumer, and industrial sectors through both minority growth positions and control buyouts. The firm led a $20 million round in AGS Health, a revenue-cycle management platform serving US hospital systems, and backed Kaleidofin, a Chennai-based fintech that builds credit-score alternatives for India's informal-economy workers. In industrials, it invested in co-working operator Incuspaze and in supply-chain financing platform CredAble. Xponentia typically writes initial equity checks of $15–25 million and reserves significant follow-on capital for portfolio companies, operating across Mumbai, Delhi, Bengaluru, and Chennai deal corridors. Fund I closed at roughly $100 million, and the firm launched Fund II in 2021 with a target of $350 million, reflecting a tripling of deployment capacity as institutional LPs deepened their India mid-market allocations. Xponentia has built an internal operating team that includes former operators from portfolio companies and Indian conglomerates — a team that works alongside founders on distribution partnerships and unit economics. As of 2023, the firm held a final close on Fund II above its target, roughly doubling its total committed capital under management compared to the prior vehicle. Xponentia's architecture stands apart from India's typical sponsor-backed growth firms because Srinivasan built the partnership with ex-operators, not ex-bankers, as a majority of its senior team. The firm's investment committee includes a former managing director from Actis and a former Tata Group executive, which gives it sourcing depth in corporate carve-outs — a deal type that most Indian mid-market GPs cannot underwrite. Xponentia's post-close playbook relies on placing operating partners inside portfolio company boardrooms rather than outsourcing value creation to third-party consultants.
General information
Firm type
Private Equity
Year founded
2014
AUM
Under $500M (Altss estimate)
Location
Region
Asia
Country
India
City
Mumbai
Corporate office
Mumbai, Maharashtra, India
Principals
P.R. Srinivasan
Founder & Managing Partner
Sector focus
Frequently asked questions
Who makes the final investment decision at Xponentia?
P.R. Srinivasan chairs the investment committee as Founder & Managing Partner, joined by senior partners with prior experience at institutions including Citi Venture Capital International, Actis, and the Tata Group. The committee requires unanimous consent for all new investments, and external limited partners do not have veto rights over individual deals. Srinivasan draws on his eight-year track record deploying over $1 billion in India while leading Citi's proprietary private equity platform in the region.
Does Xponentia focus on control buyouts or minority growth deals?
Xponentia executes both strategies depending on the opportunity. The firm targets control positions in businesses with stable cash flows and fragmented ownership structures — typically industrial and healthcare services companies — while taking significant minority stakes in growth-stage enterprise technology and financial services platforms where founders retain operational control. In minority deals, Xponentia secures board seats, veto rights over major capital allocation decisions, and pre-negotiated paths to liquidity.
What investment stages does Xponentia target?
Xponentia operates across Series B through pre-IPO growth rounds, targeting companies with $10–50 million in revenue that need capital to scale operations rather than prove product-market fit. The firm avoids seed and early-venture stages, preferring businesses with established unit economics, audited financials, and management teams that have already navigated at least one business cycle. Portfolio companies typically reach an institutional exit within five to seven years of initial investment.
How is Xponentia structured compared to other India-focused private equity firms?
Xponentia operates as a partnership with an investment committee composed primarily of former operators rather than career financiers. The firm's senior team includes professionals who previously managed businesses at Indian conglomerates and multinational corporations, which lets Xponentia lead post-close value creation internally instead of relying on external consultants. This operating-partner model differentiates it from both India's large-cap sponsor-backed funds and the country's flurry of first-time fund managers raised by former investment bankers.
Which sectors does Xponentia explicitly avoid?
Xponentia does not invest in real estate development, commodities, pure-play infrastructure projects, or heavily regulated industries such as defense manufacturing. The firm also avoids pre-revenue biotech and deep-tech ventures where the path to profitability depends on regulatory approvals rather than commercial adoption. These exclusions are structured into the fund's limited partnership agreement and have been consistent across both funds.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: